LIFESTANCE HEALTH GROUP INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Eric Palmer

LIFESTANCE HEALTH GROUP INC.’s own tally for this item (“Elect Director: Eric Palmer”): 318,312,297 for, 4,910,455 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class I for a term of three years.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 67,852,462 for, 87,203 withheld, 0 abstained.

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Description as filed by funds: Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Katherine Wood

LIFESTANCE HEALTH GROUP INC.’s own tally for this item (“Elect Director: Katherine Wood”): 245,528,506 for, 77,694,246 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class I for a term of three years.”
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 22,131,155 for, 45,808,510 withheld, 0 abstained.

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Description as filed by funds: Election of the three director nominees named in the Proxy Statement to serve until the 2028 annual meeting of stockholders: Teresa DeLuca, M.D.

LIFESTANCE HEALTH GROUP INC.’s own tally for this item (“Elect Director: Teresa DeLuca”): 292,308,309 for, 30,914,443 withheld, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class I for a term of three years.”
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 58,736,242 for, 9,203,423 withheld, 0 abstained.

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Description as filed by funds: Approval, on an advisory basis, of the compensation of the Company's named executive officers;

LIFESTANCE HEALTH GROUP INC.’s own tally for this item (“3. Advisory Vote on Named Executive Officer Compensation”): 295,914,020 for, 26,682,137 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company's named executive officer compensation.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 61 managers: 59,077,295 for, 8,896,577 against, 21,983 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 132 managers: 65,381,014 for, 20,199,025 against, 590,814 abstained, 389,786 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2025;

LIFESTANCE HEALTH GROUP INC.’s own tally for this item (“2. Ratification of the Company's Independent Registered Public Accounting Firm”): 346,473,203 for, 58,358 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ended December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 67,916,810 for, 0 against, 21,983 abstained.

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.